Recombinant TGM2 (Zampilimab Biosimilar) antibody

Catalog No. ABIN7676100

The Human Monoclonal anti-TGM2 (Zampilimab Biosimilar) antibody is suitable to detect TGM2 (Zampilimab Biosimilar) in samples from Human. It has been validated for ELISA, BLI, FACS, Func and SPR.

Quick Overview for Recombinant TGM2 (Zampilimab Biosimilar) antibody (ABIN7676100)

Target: TGM2 (Zampilimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This TGM2 (Zampilimab Biosimilar) antibody is un-conjugated

Application: ELISA, Bio-Layer Interferometry (BLI), Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-TGM2 (Zampilimab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-TGM2 / Transglutaminase 2 Reference Antibody (zampilimab)

Characteristics: Anti-TGM2 / Transglutaminase 2 Reference Antibody (zampilimab) is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG4 S228P

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for TGM2 (Zampilimab Biosimilar)

Target: TGM2 (Zampilimab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: P21980